NARA Discovery
Article Details
← Back to Search Results
Journal Article

Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)

Maria J. G. T. Vehreschild; Surabhi Taori; Simon D. Goldenberg; Florian Thalhammer; Emilio Bouza; Joop van Oene; Graham Wetherill; Areti Georgopali
European Journal of Clinical Microbiology & Infectious Diseases · Vol. 38, Issue 1 · pp. 199-199 · 2019
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalEuropean Journal of Clinical Microbiology & Infectious Diseases
PublisherSpringer
Publication Date2019-01-01
Publication Year2019
Volume38
Issue1
Pages199-199
Document TypeJournal Article
Print ISSN0934-9723
eISSN1435-4373
DOI10.1007/s10096-018-3410-8

Access Information

NARA Access Coverage1982-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10096
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.